Jeffrey C. Petherick, '85
Professional Association: VFounder, Partner, Portfolio Manager, Northpointe Capital.
Education: Albion College, 1985. University of Michigan-Ann Arbor, MBA, 1989. Chartered Financial Analyst (CFA), 1990.
In addition to his success with Northpointe Capital, Mr. Petherick serves as Board President, Impact India 360, a non-profit dedicated to sustaining an orphanage/hospital/missionary school in Eastern India, is a Founding Partner of Impact T3, and group committed to investing in social enterprises in the cities of Detroit and Pontiac, and sits on the board of two private companies, BlackLight Power and History Spots, Inc. In addition, Jeff is active in his local church, Kensing-ton Community Church in Troy, Michigan.
Mr. Petherick’s Albion College involvement included PBK, ODK/Mortar Board, Sigma Chi, a member of the Gerstacker Visiting Committee, and he is the current Investment Committee Chair for the Albion College Endowment.
Mr. Petherick and his wife, Gina Marie Petherick have a son, Chad (’10 Albion Alumni) and daughter, Kira. They live in Shelby Township.
Mr. Petherick serves as an Albion College Trustee because…
of his appreciation for the strong foundation Albion laid for him to live a fruitful and impactful life after college. As is common for Albion Alumni, Mr. Petherick believes the intrinsic “value” of his Albion College education has only increased with time and he is grateful to play a small part in ensuring this will be case in the coming decades.
Donald W. Strite, '14
Professional Association: Assurance Staff member at Ernst and Young.
Education: B.A. Degree, Albion College 2014.
Don Strite graduated from Albion College in 2014 with a degree in Economics and Management with Emphasis in Accounting.
In addition to serving as assurance staff member, Don is studying to become a Certified Public Accountant (CPA), training for Triathlons and Half/Full Marathons.
Don currently lives in Royal Oak, Michigan.
Mr. Strite serves as an Albion College Trustee because…
he found a true passion for the college after attending 4 years and creating lasting relationships with faculty and students through both academic endeavors and extracurricular activities at Albion. After taking advantage of several opportunities the college offers, Don wants to bring awareness throughout the schools to encourage students to do the same and show them the success that can come from doing so. On a larger scale, he hopes to help the college reach its full academic potential by becoming one of the most competitive liberal arts colleges in the Midwest.
James M. Wilson, '77
Professional Association: Director of the Gene Therapy Program, Department of Pathology & Laboratory Medicine; Professor, Department of Internal Medicine at the University of Pennsylvania.
Education: Albion College, 1977. M.D and Ph.D., University of Michigan, 1984.
Following a residency in Internal Medicine at the Harvard affiliated Massachusetts General Hospital and a postdoctoral fellowship at MIT, he returned to the University of Michigan where he took his first faculty position beginning his studies in gene therapy.
Dr. James M. Wilson is the Professor and Director of the Gene Therapy Program in the Department of Pathology and Laboratory Medicine, and Professor in the Department of Internal Medicine at the University of Pennsylvania.
Nineteen years ago, he moved his laboratory and family to Philadelphia and joined the faculty of the University of Pennsylvania. His research interests are gene therapy, genetic diseases, virology and vaccines for infectious diseases. A primary focus of his research has been the study of cystic fibrosis and development of new treatments based on gene therapy. Dr. Wilson has published over 497 papers and chapters in books and is on the editorial board of 12 scientific journals, serving as Editor-in-Chief of Human Gene Therapy. He is the former president of the American Society of Gene Therapy and former trustee of Albion College and the Franklin Institute. Dr. Wilson is a scientific founder of REGENX BioSciences and is a consultant to REGENX Holdings, a founding member of REGENX BioSciences.
Dennis W. Wahr, '74
Professional Association: President and CEO of Holaria, Inc.
Education: Albion College, 1974. Wayne State University, Doctor of Medicine. University of Michigan, Residency. UC San Francisco, Cardiovascular Fellowship.
Dr. Dennis W. Wahr graduated from Albion College in 1974. Following his undergraduate studies, Dr. Wahr continued his education earning his Doctor of Medicine Degree from Wayne State University. He completed his residency at the University of Michigan and completed his cardiovascular fellowship training at UC San Francisco. As a board certified interventional cardiologist, he practiced for 14 years at St. Joseph Mercy Hospital in Ann Arbor, MI before leaving practice to begin his entrepreneurial career of developing medical devices.
Dr. Wahr currently serves as President and CEO of Holaria, Inc, a private company specializing in developing products for patients who suffer from chronic lung disease.
Dr. Wahr was Co-Founder and past President of Lutonix, Inc., a venture-backed medical device startup company dedicated to developing products for the treatment of vascular disease. Lutonix was acquired by CR Bard in 2011.
Dr. Wahr was also Co-Founder and President of Velocimed, Inc., a venture-backed medical device startup company, also dedicated to developing products for the treatment of vascular disease. Velocimed was acquired by St. Jude Medical in 2005.
While at Albion, Dr. Wahr was a member of Sigma Nu Fraternity, the Men’s Basketball Team, and the Men’s Golf Team. He was inducted into the Albion College Hall of Fame in 2008. He is also a Mentor Program Volunteer.
Dr. Wahr is married to Dr. Joyce Wahr, who is a Professor of Anesthesiology at the University of Minnesota. They have three grown children, Alexa, Christine and Jennifer. The Wahr’s live in Minneapolis, Minnesota.
Dr. Wahr serves as an Albion College Trustee because…
Albion is an outstanding institution that had a positive and profound impact on his career.